Boehringer Ingelheim Vetmedica has introduced two new vaccines for use in pigs against porcine reproductive and respiratory syndrome (PRRS). Both vaccines contain a live attenuated strain of the PRRS virus. The first vaccine, Ingelvac PRRSFLEX EU, is licensed for use in piglets, while the second, ReproCyc PRRS EU, is intended for breeding gilts and sows.
The company reports that Ingelvac PRRSFLEX EU reduces respiratory clinical signs due to infection with the PRRS virus, and that it is the only piglet-specific PRRS vaccine available to UK producers. It says that the vaccine can be used for the active immunisation of healthy pigs from 17 days of age.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados